CRISPR Therapeutics AG
Veridion Score
Composite trend over time
Why is CRSP moving today?
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for CRSP.
CRSP insider activity
CRISPR Therapeutics AG
No multi-insider buying cluster in the last 90 days
Net buying: $37.9M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | 2026-05-29 | Patel Naimish | Insider | sell | $55.62 | 3,786 | 19,357 | $211K | SEC Form 4 |
| 2026-03-24 | 2026-03-23 | KASINGER JAMES R. | Insider | sell | $46.78 | 3,182 | 94,308 | $149K | SEC Form 4 |
| 2026-03-24 | 2026-03-23 | Kulkarni Samarth | Insider | sell | $46.78 | 10,020 | 255,501 | $469K | SEC Form 4 |
| 2026-03-24 | 2026-03-23 | Prasad Raju | Insider | sell | $46.78 | 3,708 | 15,565 | $173K | SEC Form 4 |
| 2026-03-17 | 2026-03-16 | Patel Naimish | Insider | sell | $48.26 | 3,150 | 13,143 | $152K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 29 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCRSP contract awards, year to date.
Public federal awards linked to this ticker.
CRSP lobbying filings, year to date.
Registered lobbying filings matched to CRISPR Therapeutics AG.